Academisch Medisch Centrum - Universiteit Van Amsterdam (amc-uva)
Clinical trials sponsored by Academisch Medisch Centrum - Universiteit Van Amsterdam (amc-uva), explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Heart failure in women: new study aims to improve surgery outcomes Results expected Sep 2026 (estimated)
- A supplement that could help heart failure patients shed excess fluid? Results expected Sep 2026 (estimated)
- Can a new drug cool down inflamed arteries and prevent heart attacks? Results expected Sep 2026 (estimated)
- Diabetes heart risk under the microscope: 1,000 patients scanned for clues Results expected Oct 2026 (estimated)
- Tailored scope schedule aims to cut cancer risk in FAP patients Results expected Nov 2026 (estimated)
-
Two strong painkillers go Head-to-Head in the ambulance
Symptom relief Stopped earlyParamedics in the Netherlands often treat severe pain after trauma with either fentanyl or esketamine, but no one knows if one works as well as the other or if a nasal spray works as well as an IV. The FORE-PAIN trial randomly assigns adults with acute traumatic pain to one of fo…
Phase 3 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Ankle sprain study seeks to predict chronic instability
Knowledge-focused Stopped earlyThis study aimed to find out which patients with an ankle sprain will go on to develop chronic ankle instability. Researchers planned to follow 460 adults who came to the emergency room after a sprain, collecting X-ray measurements and personal details like height, weight, and sp…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC